Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks.
about
Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio choleraeImproving immunization approaches to cholera.Combination vaccines against diarrheal diseases.Cholera in the United States, 2001-2011: a reflection of patterns of global epidemiology and travel.Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor.The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae.Cholera in travelers: shifting tides in epidemiology, management, and prevention.Small Intestinal Infections.Evidence for CVD 103-HgR as an effective single-dose oral cholera vaccine.Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine.Guinea pig complement potently measures vibriocidal activity of human antibodies in response to cholera vaccines.Causes of impaired oral vaccine efficacy in developing countries.PaxVax CVD 103-HgR single-dose live oral cholera vaccine.Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination.
P2860
Q27004488-26D77D94-F821-4CAF-B683-A998F8122D82Q30151668-B49F93BB-8A58-4390-A0ED-9ECB1BF6B29FQ35896237-4F98F51E-FCCB-467B-BD66-722A41CB93AAQ36191192-A018B76F-A341-428B-B5B3-194089F014C0Q36915108-AFA23295-160D-43AD-9F49-83946C877D8FQ37563642-835A9519-E465-4D52-84E3-17EAA4236CB3Q38325644-79A77051-D155-449E-A69C-B1BB041E4E54Q38832044-1B646789-C371-4B53-BC9D-B7741DF9E1C8Q38979270-6D42E176-18E5-49D6-956E-F3915437CBD8Q40217245-F95D57F5-6F8A-4016-9DC5-7F3593800E37Q46246286-306E1DAD-A61A-4995-B4DD-41A7CF77CAE3Q47794110-4922FBA8-11C1-4DB3-98E0-07B45DC837B2Q51150718-D024AD9C-FCB4-4DF5-8412-6FBE7D3672DCQ52602663-BD202ED1-AAD3-41C9-B2DF-F7C8956BC13BQ55326313-F14ABA42-47D8-40F2-AA86-8505E4641008
P2860
Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety and immunogenicity of s ...... master and working cell banks.
@en
Safety and immunogenicity of s ...... master and working cell banks.
@nl
type
label
Safety and immunogenicity of s ...... master and working cell banks.
@en
Safety and immunogenicity of s ...... master and working cell banks.
@nl
prefLabel
Safety and immunogenicity of s ...... master and working cell banks.
@en
Safety and immunogenicity of s ...... master and working cell banks.
@nl
P2093
P2860
P356
P1476
Safety and immunogenicity of s ...... master and working cell banks
@en
P2093
Marc Gurwith
Michael Lock
Richard N Greenberg
Sofie Livio
Wilbur H Chen
P2860
P356
10.1128/CVI.00601-13
P577
2013-10-30T00:00:00Z